File Download

There are no files associated with this item.

Supplementary

Conference Paper: An entirely oral regimen of oral-ato, atra and ascorbic acid in risk-adapted treatment of newly-diagnosed apl resulted in excellent clinical/molecular responses with durable remission

TitleAn entirely oral regimen of oral-ato, atra and ascorbic acid in risk-adapted treatment of newly-diagnosed apl resulted in excellent clinical/molecular responses with durable remission
Authors
Issue Date9-Jun-2023
Persistent Identifierhttp://hdl.handle.net/10722/337638

 

DC FieldValueLanguage
dc.contributor.authorSingh, Gill Harinder Harry-
dc.contributor.authorYim, Rita Lok Hay-
dc.contributor.authorChin, Zan Lynn-
dc.contributor.authorLee, Paul-
dc.contributor.authorLi, Wing Kan Vivian-
dc.contributor.authorAu, Lester Siu Shan-
dc.contributor.authorLeung, Man Kit Garret-
dc.contributor.authorKumana, Cyrus Rustam-
dc.contributor.authorKwong, Yok Lam-
dc.date.accessioned2024-03-11T10:22:43Z-
dc.date.available2024-03-11T10:22:43Z-
dc.date.issued2023-06-09-
dc.identifier.urihttp://hdl.handle.net/10722/337638-
dc.languageeng-
dc.relation.ispartofEuropean Hematology Association Annual Congress 2023 (08/06/2023-15/06/2023, Frankfurt)-
dc.titleAn entirely oral regimen of oral-ato, atra and ascorbic acid in risk-adapted treatment of newly-diagnosed apl resulted in excellent clinical/molecular responses with durable remission-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats